 Morbidity mortality quality life patients levothyroxine population study middle-aged women women levothyroxine years follow-up subjects end-point myocardial infarction mellitus stroke cancer death status initial participants women levothyroxine increase morbidity mortality women levothyroxine thyrotropin triiodothyronine concentrations with-in reference limits individuals women population study history thyroid disease identical laboratory clinical data exception body mass taller stature serum cholesterol concentration treated group life quality estimate questions life satisfaction sensory function levothyroxine-treated woman side effects life-long therapy